Tasly Holding Group

Incorporated in 1994, Tasly Holding Group has now developed to an internationalized and high-tech cooperation, engaging in pan-health industry with biological medicine industry as the core business, health industry and medical service as two supporting businesses. Guided by Chinese ancient civilization, Tasly is devoted to the philosophy “seeking for harmonization between human and nature, improving humankind life quality” . With the mission of “to share the joy of health with all”, Tasly aims to become the No. 1 in modern biological pharmaceuticals and leader of integrated health industry in China. By now, Tasly has set up a pan-health industry line, which contains six core industries,including bio-pharmaceutical industry, health products industry, herbs industry, medical industry, health management industry and children education industry. Aiming to realize TCM globalization, Tasly has been sticking to develop the international market since its foundation. By now, more than 30 types of preparation products in 8 medical categories of Tasly have been put into the international market. And the export routes cover 23 countries in America, Europe, Africa and Asia. With the distribution network spreading to more than 40 countries, Tasly’s distributor members have almost reached a million in the world. In recent years, Tasly has been listed in the top 10 of TCM exporters in China. And in 2016, Tasly Pharm. Co.,Ltd was listed in the Top 500 of Chinese Enterprises released by the US Fortune magazine.

Yan XiJun

Founder and President

14 past transactions

Hengyu Medical

Series C in 2022
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Micot

Series B in 2021
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
Ghalife is a medical device company integrating research and development, production, and sales. It is a research and industrial production that involves the development of medical devices. It involves the detection of non-invasive physiological parameters of the human body and is committed to building a chronic disease management system.

Avicanna

Post in 2020
Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space. It provides the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms, including API, medical, pharmaceutical, and derma cosmetics. As a multinational organization with vertical integration, Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions. Avicanna was founded in 2016 and is headquartered in Toronto, Ontario, Canada.

Zhangshang Tangyi

Series D in 2020
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Micot

Seed Round in 2019
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.

HOZ Medical

Angel Round in 2018
HOZ Medical is a Beijing-based neurosurgical robot developer. It focuses on the clinical application of frameless stereotactic radiosurgery in neurosurgery, to design medical robots for craniocerebral surgery.

Genova

Corporate Round in 2017
Genova is a biotechnology company focusing on the development and production of insulin.

ZYBC

Angel Round in 2017
ZYBC engages in the materials testing, evaluation & certification, and technical advisory services for traditional Chinese medicine.

PegBio

Series E in 2017
Founded in 2008, Suzhou city-based PegBio is a bio-pharmaceutical company specializing in the development of innovative drugs to combat diabetes and obesity. Its key product PB-119, an agonist of glucagon-like peptide 1 (GLP-1), allows diabetes patients to take medicine once a week, instead of requiring daily injections.

LenoMed Medical

Series A in 2017
LenoMed Medical is a medical equipment maker. Over 15-year research and development experience on infusion technology, LenoMed innovatively develop and manufacture InnoTech insulin pump, drug infusion pump and disposables. They explore innovative way to develop close-loop through integration of CGM technology and insulin pump. They share the commitment to advance diabetes management through their diabetes care management system.

AccuRad

Series B in 2016
AccuRad provides medical cloud SaaS services. They offer services that include medical imaging, ultrasound, endoscopy, nuclear medicine, and pathology.

SHU LIAN YI KANG

Series A in 2016
Chengdu Shulian Yikang Technology is a third-party company that offers medical insurance services based on big data. They provide services such as intelligent auditing, policy-making auxiliary decision-making, and medical behavior supervision for local human resources, health, and family planning committees.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.